Roselabs Finance Limited

Total Valuation

Roselabs Finance Limited carries a market capitalization of 235.30M, placing it among publicly traded companies globally. Its enterprise value stands at 291.43M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Valuation Ratios

Enterprise Valuation

Financial Position

Roselabs Finance Limited maintains a current ratio of 8.47, meaning it holds 8.5x the short-term assets needed to cover near-term liabilities.

Stock Price Statistics

Roselabs Finance Limited's stock has declined approximately -26.23824% over the past 52 weeks. The 50-day moving average sits at 21.12, while the 200-day moving average is 23.58.

Income Statement

Over the trailing twelve months, Roselabs Finance Limited generated 7.09M in revenue and converted that into -2.94M in net income, yielding earnings per share of -0.30. EBITDA reached -3.11M, while operating income came in at -3.11M.

Margins

Roselabs Finance Limited operates with a gross margin of 1.00, reflecting its pricing power and cost economics. The operating margin of -43.90 and net profit margin of -41.53 provide insight into operational efficiency.

Scores

Roselabs Finance Limited posts an Altman Z-Score of 9.28, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.